Source:http://linkedlifedata.com/resource/pubmed/id/15909293
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
1
|
| pubmed:dateCreated |
2005-7-5
|
| pubmed:abstractText |
Using a collection of Irish sib-pair nuclear families, we previously obtained modest evidence of linkage implicating 14q22-24 in bipolar disorder (BPD). To follow-up on this preliminary finding, an extended linkage analysis was performed which employed thirteen microsatellite markers, spanning a total distance of 85 cM on 14q. Effectively, P-values <0.05 were observed for a region extending over 41.88 cM, with the marker D14S281 displaying a peak multipoint non-parametric lod (NPL) score of 2.72 and an associated P-value of 0.003. Support for this finding was also obtained from flanking markers indicating excess allele sharing at 14q22-24 in Irish bipolar sib-pairs. A web-based candidate gene search of 14q22-24 resulted in the selection of GTP cyclohydrolase I (GCHI), located 200 kb 3' of D14S281, as the best plausible candidate gene for involvement in BPD. GCHI is the rate-limiting enzyme in the biosynthesis of tetrahydrobiopterin (BH(4)), a natural cofactor for tyrosine and tryptophan hydroxylases. These enzymes play an essential role in the biosynthesis of various hormones and neurotransmitters such as dopamine, noradrenaline, adrenaline, and serotonin. Numerous studies have also suggested that the clinical symptoms of depression might be related to a deficiency of BH(4). An association study between BPD and a novel single nucleotide polymorphism (SNP) in GCHI (G to A at position -959 bp, upstream of the ATG codon), is also presented here. This study revealed that the variant A allele is preferentially transmitted to BPI probands (chi(2) = 4.54, P = 0.033) suggesting that variants within GCHI may contribute to BPD in the Irish population.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Jul
|
| pubmed:issn |
1552-4841
|
| pubmed:author | |
| pubmed:copyrightInfo |
Copyright 2005 Wiley-Liss, Inc.
|
| pubmed:issnType |
Print
|
| pubmed:day |
5
|
| pubmed:volume |
136B
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
75-80
|
| pubmed:dateRevised |
2010-11-18
|
| pubmed:meshHeading |
pubmed-meshheading:15909293-Alleles,
pubmed-meshheading:15909293-Bipolar Disorder,
pubmed-meshheading:15909293-Chromosomes, Human, Pair 14,
pubmed-meshheading:15909293-DNA,
pubmed-meshheading:15909293-DNA Mutational Analysis,
pubmed-meshheading:15909293-Family Health,
pubmed-meshheading:15909293-GTP Cyclohydrolase,
pubmed-meshheading:15909293-Genetic Linkage,
pubmed-meshheading:15909293-Genetic Predisposition to Disease,
pubmed-meshheading:15909293-Genotype,
pubmed-meshheading:15909293-Humans,
pubmed-meshheading:15909293-Ireland,
pubmed-meshheading:15909293-Linkage Disequilibrium,
pubmed-meshheading:15909293-Microsatellite Repeats,
pubmed-meshheading:15909293-Mutation,
pubmed-meshheading:15909293-Polymorphism, Restriction Fragment Length,
pubmed-meshheading:15909293-Polymorphism, Single Nucleotide
|
| pubmed:year |
2005
|
| pubmed:articleTitle |
Linkage and candidate gene analysis of 14q22-24 in bipolar disorder: support for GCHI as a novel susceptibility gene.
|
| pubmed:affiliation |
Department of Pharmacology and Centre for Pharmacogenetics, University of Pennsylvania School of Medicine, Philadelphia, 19104, USA. kealeyc@mail.med.upenn.edu
|
| pubmed:publicationType |
Journal Article
|